Insiders · KTTA

KTTA insider transactions

Pasithea Therapeutics Corp. (KTTA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for KTTA

• 8d
  SEC Form 3 filed by new insider Coastlands Capital Lp

  3 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 146d
  Director Steinman Lawrence bought $100,000 worth of shares (133,333 units at $0.75), increasing direct ownership by 201% to 199,691 units (SEC Form 4)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 146d
  Chief Financial Officer Schneiderman Daniel H was granted 26,667 shares (SEC Form 4)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 146d
  Chief Executive Officer Marques Tiago bought $25,000 worth of shares (33,333 units at $0.75), increasing direct ownership by 83% to 73,334 units (SEC Form 4)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 146d
  Director Dumesnil Simon bought $25,000 worth of shares (33,333 units at $0.75), increasing direct ownership by 1,333% to 35,833 units (SEC Form 4)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 146d
  Director Leahy Emer was granted 33,333 shares (SEC Form 4)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 180d
  SEC Form 4 filed by Director Steinman Lawrence

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 180d
  SEC Form 4 filed by Chief Financial Officer Schneiderman Daniel H

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 180d
  SEC Form 4 filed by Chief Executive Officer Marques Tiago

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 180d
  SEC Form 4 filed by Director Leahy Emer

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 180d
  SEC Form 4 filed by Director Dumesnil Simon

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 180d
  SEC Form 4 filed by Director Novak Alfred J

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 346d
  Chief Executive Officer Marques Tiago sold $792 worth of shares (960 units at $0.82), decreasing direct ownership by 2% to 40,001 units (SEC Form 4)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 680d
  Director Novak Alfred J was granted 3,500 shares (SEC Form 4)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 750d
  SEC Form 4 filed by Marques Tiago (Amendment)

  4/A - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 750d
  SEC Form 4 filed by Schneiderman Daniel H (Amendment)

  4/A - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 750d
  SEC Form 4 filed by Dumesnil Simon (Amendment)

  4/A - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 750d
  SEC Form 4 filed by Leahy Emer (Amendment)

  4/A - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 750d
  SEC Form 4 filed by Novak Alfred J (Amendment)

  4/A - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 750d
  SEC Form 4 filed by Steinman Lawrence (Amendment)

  4/A - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 750d
  SEC Form 4 filed by Currie Graeme Martin (Amendment)

  4/A - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 785d
  SEC Form 4 filed by Steinman Lawrence

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 785d
  SEC Form 4 filed by Schneiderman Daniel H

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 785d
  SEC Form 4 filed by Novak Alfred J

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 785d
  SEC Form 4 filed by Marques Tiago

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 785d
  SEC Form 4 filed by Leahy Emer

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 785d
  SEC Form 4 filed by Dumesnil Simon

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 785d
  SEC Form 4 filed by Currie Graeme Martin

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1027d
  SEC Form 3 filed by new insider Currie Graeme Martin

  3 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1054d
  SEC Form 4 filed by Steinman Lawrence (Amendment)

  4/A - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1054d
  SEC Form 4 filed by Steinman Lawrence

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1166d
  SEC Form 3: New insider Pd Joint Holdings, Llc Series 2016-A claimed ownership of 2,608,696 shares

  3 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1244d
  SEC Form 4: Steinman Lawrence was granted 5,000 shares, increasing direct ownership by 0.39% to 1,287,174 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1244d
  SEC Form 4: Marques Tiago was granted 9,206 shares, increasing direct ownership by 1% to 819,206 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1250d
  SEC Form 4: Steinman Lawrence was granted 5,000 shares, increasing direct ownership by 0.39% to 1,282,174 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1255d
  SEC Form 4: Dumesnil Simon was granted 50,000 shares

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1277d
  SEC Form 4: Steinman Lawrence was granted 5,000 shares, increasing direct ownership by 0.39% to 1,277,174 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1280d
  SEC Form 4 filed by Novak Alfred J

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1282d
  SEC Form 4: Marques Tiago was granted 5,000 shares, increasing direct ownership by 0.62% to 810,000 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1284d
  SEC Form 4: Delaney David bought $1,110 worth of shares (1,000 units at $1.11)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1286d
  SEC Form 4: Steinman Lawrence was granted 10,000 shares, increasing direct ownership by 0.79% to 1,272,174 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1291d
  SEC Form 4 filed by Schneiderman Daniel H

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1303d
  SEC Form 4: Shahinian Eric bought $76,299 worth of shares (64,357 units at $1.19)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1314d
  SEC Form 3 filed by new insider Novak Alfred J

  3 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1327d
  SEC Form 4: Shahinian Eric bought $100,367 worth of shares (88,901 units at $1.13)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1333d
  SEC Form 4: Shahinian Eric bought $26,293 worth of shares (22,828 units at $1.15)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1338d
  SEC Form 4: Geller Avi bought $70,939 worth of shares (54,644 units at $1.30)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1338d
  SEC Form 3 filed by new insider Leonite Fund I, Lp

  3 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1346d
  SEC Form 4: Shahinian Eric bought $188,283 worth of shares (155,773 units at $1.21)

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1348d
  SEC Form 3: New insider Delaney David claimed ownership of 226,521 shares

  3 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1349d
  SEC Form 3 filed by new insider Schneiderman Daniel H

  3 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1350d
  SEC Form 3: New insider Shahinian Eric claimed ownership of 1,455,556 shares

  3 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1350d
  SEC Form 3: New insider Geller Avi claimed ownership of 1,034,702 shares

  3 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1395d
  SEC Form 4: Steinman Lawrence was granted 10,000 shares, increasing direct ownership by 0.79% to 1,272,174 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1398d
  SEC Form 4: Steinman Lawrence was granted 5,000 shares, increasing direct ownership by 0.40% to 1,262,174 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1402d
  SEC Form 4: Marques Tiago was granted 5,000 shares, increasing direct ownership by 0.62% to 805,000 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1402d
  SEC Form 4: Steinman Lawrence was granted 5,000 shares, increasing direct ownership by 0.40% to 1,257,174 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1403d
  SEC Form 4: Steinman Lawrence was granted 652,174 shares, increasing direct ownership by 109% to 1,252,174 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1585d
  SEC Form 4: Marques Tiago was granted 200,000 shares, increasing direct ownership by 33% to 800,000 units

  4 - Pasithea Therapeutics Corp. (0001841330) (Issuer)
• 1661d
  SEC Form 3: New insider Abramowitz Israel Maxx claimed ownership of 1,051,575 shares (Amendment)

  3/A - Pasithea Therapeutics Corp. (0001841330) (Issuer)